Zobrazeno 1 - 10
of 90
pro vyhledávání: '"Rong-cheng Li"'
Autor:
Li-Wei Shi, Juan Li, Bang-Wei Yu, Li-Rong Huang, Ke Li, Min Ji, Ling-Yun Zhou, Lin Yuan, Shu-Yuan Yang, Jing-Jing Chen, Ling Wang, Zhi-Wei Jiang, Rong-Cheng Li, Yan-Ping Li, Jie-Lai Xia, Zhao-Jun Mo, Chang-Gui Li
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 19, Iss 1 (2023)
As global supply is still inadequate to address the worldwide requirements for HPV vaccines, we assessed the safety and immunogenicity of a new bivalent HPV16/18 vaccine. In this randomized, double-blind, placebo-controlled, phase 2 trial, healthy 9
Externí odkaz:
https://doaj.org/article/37b633ed5f81434997610880eb25cc07
Autor:
Hong-Lu Zhou, Theresa Bessey, Song-Mei Wang, Zhao-Jun Mo, Leslie Barclay, Jin-Xia Wang, Can-Jing Zhang, Jing-Chen Ma, Chao Qiu, Gan Zhao, Rong-Cheng Li, Yu-Liang Zhao, Baoming Jiang, Xuan-Yi Wang
Publikováno v:
Gut Pathogens, Vol 13, Iss 1, Pp 1-11 (2021)
Key Points Currently bacterial and viral agents in the gastrointestinal tract are under-detected and poorly defined in developing countries. A new sensitive TAC assay provided comprehensive identification of microorganisms, including neglected pathog
Externí odkaz:
https://doaj.org/article/b91ddd559f3e42f3a2c6a135f2221530
Autor:
Ying-Ying Su, Bi-Zhen Lin, Hui Zhao, Juan Li, Zhi-Jie Lin, You-Lin Qiao, Li-Hui Wei, Yue-Mei Hu, Rong-Cheng Li, Si-Jie Zhuang, Guang Sun, Zi-Zheng Zheng, Shou-Jie Huang, Ting Wu, Jun Zhang, Hui-Rong Pan, Chang-Gui Li
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 16, Iss 7, Pp 1636-1644 (2020)
An Escherichia. coli-produced HPV-16/18 bivalent vaccine has been proved to be well-tolerated and highly efficacious against diseases associated with vaccine HPV types. As a part of the multi-center, randomized, double-blind phase III clinical trial,
Externí odkaz:
https://doaj.org/article/2bb29e18c5b24cec9d8cb82ec37b075b
Autor:
Xiao-Juan Yu, Juan Li, Zhi-Jie Lin, Hui Zhao, Bi-Zhen Lin, You-Lin Qiao, Yue-Mei Hu, Li-Hui Wei, Rong-Cheng Li, Wei-Dan Huang, Ting Wu, Shou-Jie Huang, Chang-Gui Li, Hui-Rong Pan, Jun Zhang
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 16, Iss 7, Pp 1630-1635 (2020)
A new Escherichia coli-produced human papillomavirus (HPV)-16/18 vaccine has been shown to be safe and highly efficacious and was recently licensed in China. As a post hoc analysis of the phase III trial, this study aimed to assess the impact of vacc
Externí odkaz:
https://doaj.org/article/f6f04c329b8b413ba6589fac5322afba
Autor:
Jin-Xia Wang, Hong-Lu Zhou, Zhao-Jun Mo, Song-Mei Wang, Zhi-Yong Hao, Yue Li, Shan-Shan Zhen, Can-Jing Zhang, Xin-Jiang Zhang, Jing-Chen Ma, Chao Qiu, Gan Zhao, Baoming Jiang, Xi Jiang, Rong-Cheng Li, Yu-Liang Zhao, Xuan-Yi Wang
Publikováno v:
International Journal of Infectious Diseases, Vol 90, Iss , Pp 151-160 (2020)
Background: Despite the considerable disease burden caused by the disease, rotavirus vaccine has not been introduced into routine national immunization schedule, and norovirus vaccines are being developed without a comprehensive understanding of gast
Externí odkaz:
https://doaj.org/article/887d25eede58486baf94f945c81a8df5
Autor:
Rong-Cheng Li, Sheng-Xiang Ge, Yan-Ping Li, Ying-Jie Zheng, Yi Nong, Qing-Shun Guo, Jun Zhang, Mun-Hon Ng, Ning-Shao Xia
Publikováno v:
Emerging Infectious Diseases, Vol 12, Iss 11, Pp 1682-1688 (2006)
Genotype 4 hepatitis E virus (HEV) is the dominant cause of hepatitis E in the People's Republic of China; swine are the principal reservoir. Our study was conducted in 8 rural communities of southern China, where families keep pigs near their homes.
Externí odkaz:
https://doaj.org/article/1384f7f745cc4c77af66550614a0c3e2
Autor:
Li Wang, Xiao-Pan Wu, Wei Zhang, Da-Hai Zhu, Ying Wang, Yan-Ping Li, Yao Tian, Rong-Cheng Li, Zhuo Li, Xinlin Zhu, Jun-Hong Li, Jun Cai, Li Liu, Xiao-Ping Miao, Ying Liu, Hui Li
Publikováno v:
PLoS ONE, Vol 6, Iss 3, p e17608 (2011)
BACKGROUND: A recent genome-wide scan has identified two genetic variants in the HLA-DP region strongly associated with hepatitis B infection in Japanese. This study evaluates the effects of these risk variants in Chinese, where the HBV infection is
Externí odkaz:
https://doaj.org/article/f1dc89aeb0a14030924d43d60b02f8db
Autor:
Juan Li, Li-Wei Shi, Bang-Wei Yu, Li-Rong Huang, Ling-Yun Zhou, Li Shi, Zhi-Wei Jiang, Jie-Lai Xia, Xuan-Yi Wang, Rong-Cheng Li, Lin Yuan, Yan-Ping Li, Chang-Gui Li
Publikováno v:
Vaccine. 41:3141-3149
Autor:
Yingying Su, Bizhen Lin, Sijie Zhuang, Shoujie Huang, Hui Zhao, Juan Li, Rong-Cheng Li, You-Lin Qiao, Changgui Li, Guang Sun, Zizheng Zheng, Huirong Pan, Yuemei Hu, Zhijie Lin, Lihui Wei, Jun Zhang, Ting Wu
Publikováno v:
Hum Vaccin Immunother
An Escherichia. coli-produced HPV-16/18 bivalent vaccine has been proved to be well-tolerated and highly efficacious against diseases associated with vaccine HPV types. As a part of the multi-center, randomized, double-blind phase III clinical trial,
Autor:
Jing-Chen Ma, Leslie Barclay, Baoming Jiang, Can-Jing Zhang, Yu-Liang Zhao, Song-Mei Wang, Xuan-Yi Wang, Zhao-Jun Mo, Theresa K. Bessey, Gan Zhao, Rong-Cheng Li, Jin-Xia Wang, Hong-Lu Zhou, Chao Qiu
Publikováno v:
Gut Pathogens, Vol 13, Iss 1, Pp 1-11 (2021)
Gut Pathogens
Gut Pathogens
Background Diarrhea remains the leading cause of childhood illness in China. Better understanding of burden and etiology of diarrheal diseases is important for development of effective prevention measures. Methods Population-based diarrhea surveillan